239 related articles for article (PubMed ID: 24526294)
1. Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Learmonth YC; Hubbard EA; McAuley E; Motl RW
Qual Life Res; 2014 Sep; 23(7):2015-23. PubMed ID: 24526294
[TBL] [Abstract][Full Text] [Related]
2. Does the relationship between physical activity and quality of life differ based on generic versus disease-targeted instruments?
Motl RW; McAuley E; Snook EM; Gliottoni RC
Ann Behav Med; 2008 Aug; 36(1):93-9. PubMed ID: 18719976
[TBL] [Abstract][Full Text] [Related]
3. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653
[TBL] [Abstract][Full Text] [Related]
4. Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.
Rosti-Otajärvi E; Hämäläinen P; Wiksten A; Hakkarainen T; Ruutiainen J
Brain Behav; 2017 Jul; 7(7):e00725. PubMed ID: 28729932
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.
Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ
Mult Scler; 2003 Aug; 9(4):411-9. PubMed ID: 12926848
[TBL] [Abstract][Full Text] [Related]
6. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Goodwin E; Green C; Spencer A
Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
[TBL] [Abstract][Full Text] [Related]
7. Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Lucas-Carrasco R; Sastre-Garriga J; Galán I; Den Oudsten BL; Power MJ
Disabil Rehabil; 2014; 36(12):1001-5. PubMed ID: 23962197
[TBL] [Abstract][Full Text] [Related]
8. The Preference-Based Multiple Sclerosis Index: an assessment of its psychometric properties and translation into Turkish.
Kahraman T; Ozdogar AT; Abasiyanik Z; Sagici O; Baba C; Ertekin O; Ozakbas S
Disabil Rehabil; 2023 Apr; 45(8):1412-1418. PubMed ID: 35387534
[TBL] [Abstract][Full Text] [Related]
9. Translation, cross-cultural adaptation and validation of the Persian version of COOP/WONCA charts in Persian-speaking Iranians with multiple sclerosis.
Taghipour M; Salavati M; Nabavi SM; Akhbari B; Ebrahimi Takamjani I; Negahban H; Rajabzadeh F
Disabil Rehabil; 2018 Mar; 40(6):667-672. PubMed ID: 28637139
[TBL] [Abstract][Full Text] [Related]
10. Measurement properties of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ): a study based on Classical Test Theory.
van Leeuwen LM; Mokkink LB; Kamm CP; de Groot V; van den Berg P; Ostelo RWJG; Uitdehaag BMJ
Disabil Rehabil; 2017 Oct; 39(20):2097-2104. PubMed ID: 27665841
[TBL] [Abstract][Full Text] [Related]
11. A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
Goodwin E; Green C
Value Health; 2015 Dec; 18(8):1016-24. PubMed ID: 26686786
[TBL] [Abstract][Full Text] [Related]
12. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
13. Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.
Ramp M; Khan F; Misajon RA; Pallant JF
Health Qual Life Outcomes; 2009 Jun; 7():58. PubMed ID: 19545445
[TBL] [Abstract][Full Text] [Related]
14. The validity and test-retest reliability of the Leeds Multiple Sclerosis Quality of Life scale in Turkish patients.
Akbiyik DI; Sumbuloglu V; Guney Z; Armutlu K; Korkmaz N; Keser I; Yuksel MM; Karabudak R
Int J Rehabil Res; 2009 Jun; 32(2):162-6. PubMed ID: 19369887
[TBL] [Abstract][Full Text] [Related]
15. Psychometric evaluation of the Short Form 36 Health Survey (SF-36) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) for patients with schizophrenia.
Su CT; Ng HS; Yang AL; Lin CY
Psychol Assess; 2014 Sep; 26(3):980-9. PubMed ID: 24796341
[TBL] [Abstract][Full Text] [Related]
16. Structural and construct validity of the Leeds Multiple Sclerosis Quality of Life scale.
Ensari I; Motl RW; McAuley E
Qual Life Res; 2016 Jun; 25(6):1605-11. PubMed ID: 26660145
[TBL] [Abstract][Full Text] [Related]
17. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
Hobart J; Lamping D; Fitzpatrick R; Riazi A; Thompson A
Brain; 2001 May; 124(Pt 5):962-73. PubMed ID: 11335698
[TBL] [Abstract][Full Text] [Related]
18. Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.
van der Linden FA; Kragt JJ; Klein M; van der Ploeg HM; Polman CH; Uitdehaag BM
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1677-81. PubMed ID: 16291893
[TBL] [Abstract][Full Text] [Related]
19. Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review.
Zahir F; Hanman A; Yazdani N; La Rosa S; Sleik G; Sullivan B; Mehdipour A; Malouka S; Kuspinar A
Qual Life Res; 2023 Sep; 32(9):2447-2462. PubMed ID: 36881218
[TBL] [Abstract][Full Text] [Related]
20. Measuring HRQoL following heart valve surgery: the HeartQoL questionnaire is a valid and reliable core heart disease instrument.
Grønset CN; Thygesen LC; Berg SK; Zangger G; Kristensen MS; Sibilitz KL; Pedersen SS; Oldridge NB; Zwisler AD
Qual Life Res; 2019 May; 28(5):1245-1253. PubMed ID: 30610503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
